Sometimes the degree of fraud that takes place in the drug industry is so mind-boggling that it's hard to determine whether drug regulators and the media are paying attention at all. For the past several months, drug giant GlaxoSmithKline (GSK) has been under scrutiny for tampering with clinical trial data for its diabetes drug, Avandia. Reports show that the company lied about Avandia's safety in order to get the drug approved and keep it on the market. But despite numerous pieces of credible evidence and witness testimonies that have all come forward -- all of which reveal GSK's deception -- an FDA advisory panel is still recommending that Avandia remain on the market.
Avandia fraud explained: Why Big Pharma keeps lying about its drugs
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment